File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Utilisation of medications to lower blood pressure, glucose and lipids among people with type 2 diabetes in the National Health and Nutrition Examination Survey 1999-2010

TitleUtilisation of medications to lower blood pressure, glucose and lipids among people with type 2 diabetes in the National Health and Nutrition Examination Survey 1999-2010
Other TitlesUtilization of medications to lower blood pressure, glucose and lipids among people with type 2 diabetes in the National Health and Nutrition Examination Survey 1999-2010
Authors
Issue Date2015
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/
Citation
The 20th Medical Research Conference (MRC 2015), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 54, abstract no. 89 How to Cite?
AbstractOBJECTIVE: Changes in drug treatment of diabetes in the United States were studied using data from the National Health and Nutrition Examination Survey 1999-2010. METHODS: Data on 3094 participants aged ≥20 years with diagnosed type 2 diabetes were analysed. The use of medications for lowering blood glucose, blood pressure (BP), and lipids in the past month was assessed by questionnaire. Data from two survey cycles were combined together to produce estimates for each 4-year period. RESULTS: Usage of all three types of medications increased significantly from 1999-2002 to 2007-2010 (P < 0.01). Metformin was increasingly used from 34.8% to 53.8% during this period (P<7.0% in 2007-2010. Dipeptidyl peptidase-4 (DPP-4) inhibitors, approved in 2007, were used by 7.4% of the participants in 2007-2010. Usage of angiotensin receptor blockers (ARB) and beta-blockers increased from 7.4% to 21.4%, and from 15.3% to 31.8%, respectively, across the 12-year period (both P < 0.001). 52.2% of subjects took statins by 2007-2010 (P < 0.001). CONCLUSION: There were significant increases in the use of glucose, BP, and lipid-lowering medications during 1999-2010, especially in the use of metformin, ARB and beta-blockers. The increased BP drug prescription could lead to improved BP control. Metformin is the recommended first-line drug for diabetes, while DPP-4 inhibitors began to be used after their introduction. Although statins were widely used, about half of the participants did not take them.
Persistent Identifierhttp://hdl.handle.net/10722/232422
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorWong, HK-
dc.contributor.authorLeung, YH-
dc.contributor.authorOng, KL-
dc.contributor.authorCheung, CL-
dc.contributor.authorCheung, TT-
dc.contributor.authorCheung, BMY-
dc.date.accessioned2016-09-20T05:29:52Z-
dc.date.available2016-09-20T05:29:52Z-
dc.date.issued2015-
dc.identifier.citationThe 20th Medical Research Conference (MRC 2015), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 54, abstract no. 89-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/232422-
dc.description.abstractOBJECTIVE: Changes in drug treatment of diabetes in the United States were studied using data from the National Health and Nutrition Examination Survey 1999-2010. METHODS: Data on 3094 participants aged ≥20 years with diagnosed type 2 diabetes were analysed. The use of medications for lowering blood glucose, blood pressure (BP), and lipids in the past month was assessed by questionnaire. Data from two survey cycles were combined together to produce estimates for each 4-year period. RESULTS: Usage of all three types of medications increased significantly from 1999-2002 to 2007-2010 (P < 0.01). Metformin was increasingly used from 34.8% to 53.8% during this period (P<7.0% in 2007-2010. Dipeptidyl peptidase-4 (DPP-4) inhibitors, approved in 2007, were used by 7.4% of the participants in 2007-2010. Usage of angiotensin receptor blockers (ARB) and beta-blockers increased from 7.4% to 21.4%, and from 15.3% to 31.8%, respectively, across the 12-year period (both P < 0.001). 52.2% of subjects took statins by 2007-2010 (P < 0.001). CONCLUSION: There were significant increases in the use of glucose, BP, and lipid-lowering medications during 1999-2010, especially in the use of metformin, ARB and beta-blockers. The increased BP drug prescription could lead to improved BP control. Metformin is the recommended first-line drug for diabetes, while DPP-4 inhibitors began to be used after their introduction. Although statins were widely used, about half of the participants did not take them.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.titleUtilisation of medications to lower blood pressure, glucose and lipids among people with type 2 diabetes in the National Health and Nutrition Examination Survey 1999-2010-
dc.title.alternativeUtilization of medications to lower blood pressure, glucose and lipids among people with type 2 diabetes in the National Health and Nutrition Examination Survey 1999-2010-
dc.typeConference_Paper-
dc.identifier.emailLeung, YH: yhleung@hku.hk-
dc.identifier.emailOng, KL: okl2000@hkucc.hku.hk-
dc.identifier.emailCheung, CL: lung1212@hku.hk-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityCheung, CL=rp01749-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.hkuros265123-
dc.identifier.volume21-
dc.identifier.issuesuppl. 1-
dc.identifier.spage54, abstract no. 89-
dc.identifier.epage54, abstract no. 89-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats